These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 31134494)

  • 1. Heterogeneity of Small Cell Lung Cancer Stem Cells.
    Prabavathy D; Ramadoss N
    Adv Exp Med Biol; 2019; 1139():41-57. PubMed ID: 31134494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SCLC-State of the Art and What Does the Future Have in Store?
    Kahnert K; Kauffmann-Guerrero D; Huber RM
    Clin Lung Cancer; 2016 Sep; 17(5):325-333. PubMed ID: 27397481
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evolutionary trajectories of small cell lung cancer under therapy.
    George J; Maas L; Abedpour N; Cartolano M; Kaiser L; Fischer RN; Scheel AH; Weber JP; Hellmich M; Bosco G; Volz C; Mueller C; Dahmen I; John F; Alves CP; Werr L; Panse JP; Kirschner M; Engel-Riedel W; Jürgens J; Stoelben E; Brockmann M; Grau S; Sebastian M; Stratmann JA; Kern J; Hummel HD; Hegedüs B; Schuler M; Plönes T; Aigner C; Elter T; Toepelt K; Ko YD; Kurz S; Grohé C; Serke M; Höpker K; Hagmeyer L; Doerr F; Hekmath K; Strapatsas J; Kambartel KO; Chakupurakal G; Busch A; Bauernfeind FG; Griesinger F; Luers A; Dirks W; Wiewrodt R; Luecke A; Rodermann E; Diel A; Hagen V; Severin K; Ullrich RT; Reinhardt HC; Quaas A; Bogus M; Courts C; Nürnberg P; Becker K; Achter V; Büttner R; Wolf J; Peifer M; Thomas RK
    Nature; 2024 Mar; 627(8005):880-889. PubMed ID: 38480884
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Origins, genetic landscape, and emerging therapies of small cell lung cancer.
    Semenova EA; Nagel R; Berns A
    Genes Dev; 2015 Jul; 29(14):1447-62. PubMed ID: 26220992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NOTCH, ASCL1, p53 and RB alterations define an alternative pathway driving neuroendocrine and small cell lung carcinomas.
    Meder L; König K; Ozretić L; Schultheis AM; Ueckeroth F; Ade CP; Albus K; Boehm D; Rommerscheidt-Fuss U; Florin A; Buhl T; Hartmann W; Wolf J; Merkelbach-Bruse S; Eilers M; Perner S; Heukamp LC; Buettner R
    Int J Cancer; 2016 Feb; 138(4):927-38. PubMed ID: 26340530
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ASCL1 represses a SOX9
    Olsen RR; Ireland AS; Kastner DW; Groves SM; Spainhower KB; Pozo K; Kelenis DP; Whitney CP; Guthrie MR; Wait SJ; Soltero D; Witt BL; Quaranta V; Johnson JE; Oliver TG
    Genes Dev; 2021 Jun; 35(11-12):847-869. PubMed ID: 34016693
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinicopathological significance of cancer stem-like cell markers in high-grade neuroendocrine carcinoma of the lung.
    Morise M; Hishida T; Takahashi A; Yoshida J; Ohe Y; Nagai K; Ishii G
    J Cancer Res Clin Oncol; 2015 Dec; 141(12):2121-30. PubMed ID: 25963795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetically-engineered mouse models of small cell lung cancer: the next generation.
    Oser MG; MacPherson D; Oliver TG; Sage J; Park KS
    Oncogene; 2024 Feb; 43(7):457-469. PubMed ID: 38191672
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Next-Generation Sequencing of Pulmonary Large Cell Neuroendocrine Carcinoma Reveals Small Cell Carcinoma-like and Non-Small Cell Carcinoma-like Subsets.
    Rekhtman N; Pietanza MC; Hellmann MD; Naidoo J; Arora A; Won H; Halpenny DF; Wang H; Tian SK; Litvak AM; Paik PK; Drilon AE; Socci N; Poirier JT; Shen R; Berger MF; Moreira AL; Travis WD; Rudin CM; Ladanyi M
    Clin Cancer Res; 2016 Jul; 22(14):3618-29. PubMed ID: 26960398
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A unique small cell lung carcinoma disease progression model shows progressive accumulation of cancer stem cell properties and CD44 as a potential diagnostic marker.
    Heng WS; Pore M; Meijer C; Hiltermann TJN; Cheah SC; Gosens R; Kruyt FAE
    Lung Cancer; 2021 Apr; 154():13-22. PubMed ID: 33607458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic and clonal dissection of murine small cell lung carcinoma progression by genome sequencing.
    McFadden DG; Papagiannakopoulos T; Taylor-Weiner A; Stewart C; Carter SL; Cibulskis K; Bhutkar A; McKenna A; Dooley A; Vernon A; Sougnez C; Malstrom S; Heimann M; Park J; Chen F; Farago AF; Dayton T; Shefler E; Gabriel S; Getz G; Jacks T
    Cell; 2014 Mar; 156(6):1298-1311. PubMed ID: 24630729
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular characterisation of side population cells with cancer stem cell-like characteristics in small-cell lung cancer.
    Salcido CD; Larochelle A; Taylor BJ; Dunbar CE; Varticovski L
    Br J Cancer; 2010 May; 102(11):1636-44. PubMed ID: 20424609
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pre-clinical models of small cell lung cancer and the validation of therapeutic targets.
    Sui JSY; Martin P; Gray SG
    Expert Opin Ther Targets; 2020 Mar; 24(3):187-204. PubMed ID: 32068452
    [No Abstract]   [Full Text] [Related]  

  • 14. Small Cell Lung Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology.
    Ganti AKP; Loo BW; Bassetti M; Blakely C; Chiang A; D'Amico TA; D'Avella C; Dowlati A; Downey RJ; Edelman M; Florsheim C; Gold KA; Goldman JW; Grecula JC; Hann C; Iams W; Iyengar P; Kelly K; Khalil M; Koczywas M; Merritt RE; Mohindra N; Molina J; Moran C; Pokharel S; Puri S; Qin A; Rusthoven C; Sands J; Santana-Davila R; Shafique M; Waqar SN; Gregory KM; Hughes M
    J Natl Compr Canc Netw; 2021 Dec; 19(12):1441-1464. PubMed ID: 34902832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular subtyping of small-cell lung cancer based on mutational signatures with different genomic features and therapeutic strategies.
    Wang H; Wu S; Li Z; Zhang C; Shang X; Zhao C; Li Z; Lin J; Guo J; Wang Z
    Cancer Sci; 2023 Feb; 114(2):665-679. PubMed ID: 36178064
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer Stem Cells, Epithelial to Mesenchymal Markers, and Circulating Tumor Cells in Small Cell Lung Cancer.
    Pore M; Meijer C; de Bock GH; Boersma-van Ek W; Terstappen LW; Groen HJ; Timens W; Kruyt FA; Hiltermann TJ
    Clin Lung Cancer; 2016 Nov; 17(6):535-542. PubMed ID: 27363902
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    Voigt E; Wallenburg M; Wollenzien H; Thompson E; Kumar K; Feiner J; McNally M; Friesen H; Mukherjee M; Afeworki Y; Kareta MS
    Mol Cancer Res; 2021 Dec; 19(12):2015-2025. PubMed ID: 34593608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MYC Drives Progression of Small Cell Lung Cancer to a Variant Neuroendocrine Subtype with Vulnerability to Aurora Kinase Inhibition.
    Mollaoglu G; Guthrie MR; Böhm S; Brägelmann J; Can I; Ballieu PM; Marx A; George J; Heinen C; Chalishazar MD; Cheng H; Ireland AS; Denning KE; Mukhopadhyay A; Vahrenkamp JM; Berrett KC; Mosbruger TL; Wang J; Kohan JL; Salama ME; Witt BL; Peifer M; Thomas RK; Gertz J; Johnson JE; Gazdar AF; Wechsler-Reya RJ; Sos ML; Oliver TG
    Cancer Cell; 2017 Feb; 31(2):270-285. PubMed ID: 28089889
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of LSD1 with Bomedemstat Sensitizes Small Cell Lung Cancer to Immune Checkpoint Blockade and T-Cell Killing.
    Hiatt JB; Sandborg H; Garrison SM; Arnold HU; Liao SY; Norton JP; Friesen TJ; Wu F; Sutherland KD; Rienhoff HY; Martins R; Houghton AM; Srivastava S; MacPherson D
    Clin Cancer Res; 2022 Oct; 28(20):4551-4564. PubMed ID: 35920742
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lineage-restricted neoplasia driven by Myc defaults to small cell lung cancer when combined with loss of p53 and Rb in the airway epithelium.
    Chen J; Guanizo A; Luong Q; Jayasekara WSN; Jayasinghe D; Inampudi C; Szczepny A; Garama DJ; Russell PA; Ganju V; Cain JE; Watkins DN; Gough DJ
    Oncogene; 2022 Jan; 41(1):138-145. PubMed ID: 34675406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.